69 related articles for article (PubMed ID: 24494715)
1. Fitness valleys constrain HIV-1's adaptation to its secondary chemokine coreceptor.
da Silva J; Wyatt SK
J Evol Biol; 2014 Mar; 27(3):604-15. PubMed ID: 24494715
[TBL] [Abstract][Full Text] [Related]
2. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
3. How Often Do Protein Genes Navigate Valleys of Low Fitness?
Nelson ED; Grishin NV
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30965625
[TBL] [Abstract][Full Text] [Related]
4. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
5. Fitness-valley crossing with generalized parent-offspring transmission.
Osmond MM; Otto SP
Theor Popul Biol; 2015 Nov; 105():1-16. PubMed ID: 26321054
[TBL] [Abstract][Full Text] [Related]
6. The rate at which asexual populations cross fitness valleys.
Weissman DB; Desai MM; Fisher DS; Feldman MW
Theor Popul Biol; 2009 Jun; 75(4):286-300. PubMed ID: 19285994
[TBL] [Abstract][Full Text] [Related]
7. The competition between simple and complex evolutionary trajectories in asexual populations.
Ochs IE; Desai MM
BMC Evol Biol; 2015 Mar; 15():55. PubMed ID: 25881244
[TBL] [Abstract][Full Text] [Related]
8. Correlation of coreceptor usage and disease progression.
Verhofstede C; Nijhuis M; Vandekerckhove L
Curr Opin HIV AIDS; 2012 Sep; 7(5):432-9. PubMed ID: 22871636
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the role of population subdivision in evolution on rugged fitness landscapes.
Bitbol AF; Schwab DJ
PLoS Comput Biol; 2014 Aug; 10(8):e1003778. PubMed ID: 25122220
[TBL] [Abstract][Full Text] [Related]
10. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor.
Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM
Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116
[TBL] [Abstract][Full Text] [Related]
11. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor.
Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE
Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056
[TBL] [Abstract][Full Text] [Related]
12. Fitness variation in isogenic populations leads to a novel evolutionary mechanism for crossing fitness valleys.
Van Egeren D; Madsen T; Michor F
Commun Biol; 2018; 1():151. PubMed ID: 30272027
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates.
Verani A; Pesenti E; Polo S; Tresoldi E; Scarlatti G; Lusso P; Siccardi AG; Vercelli D
J Immunol; 1998 Sep; 161(5):2084-8. PubMed ID: 9725197
[TBL] [Abstract][Full Text] [Related]
14. The rate of fitness-valley crossing in sexual populations.
Weissman DB; Feldman MW; Fisher DS
Genetics; 2010 Dec; 186(4):1389-410. PubMed ID: 20923976
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
[TBL] [Abstract][Full Text] [Related]
16. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
17. Genetic analyses of cis-acting sequences controlling expression of human immunodeficiency virus type 1 coreceptor-CCR5 gene in rabbits and CXCR4 gene in monkeys.
Shanmugasundaram GK; Sundaresan G; Shoeb F; Arumugam N; Kumaravelu J; Unwalla H; Chakraborti S; Banerjea AC
J Hum Virol; 2001; 4(4):188-94. PubMed ID: 11694846
[TBL] [Abstract][Full Text] [Related]
18. Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.
Isaka Y; Sato A; Miki S; Kawauchi S; Sakaida H; Hori T; Uchiyama T; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1999 Nov; 264(1):237-43. PubMed ID: 10544150
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.
Gabuzda D; Wang J
J Neurovirol; 2000 May; 6 Suppl 1():S24-32. PubMed ID: 10871762
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
